CRO makes the list for the fifth consecutive year
WILMINGTON, N.C., Aug. 19,
2024 /PRNewswire/ -- Catalyst Clinical
Research joined the 2024 Inc. 5000 list of the nation's
fastest-growing private companies for its fifth consecutive year.
This year Catalyst earned a spot at 2,740 with 185% growth during
the past three years.
"We are honored to be recognized on the Inc. 5000, joining an
incredible list of impressive companies. During a period of our
global expansion, Catalyst continues to deliver high-quality
clinical research services for our clients," says Nik Morton, President and CEO of Catalyst
Clinical Research. "Our culture drives our Catalyst teams to
support our clients and partners, ultimately helping to serve
patients."
Founded in 2013, Catalyst has grown from one North Carolina-based office to ten locations
and hundreds of team members around the world. With this rapid
growth, Catalyst has maintained a people-first culture, as
evidenced by its industry-leading 12-month retention rate of 91%
and an employee engagement rate of 96% in the most recent calendar
year.
Complete Inc. 5000 results, including company profiles sorted by
industry, region, and other criteria, can be found
at Inc.com/inc5000.
About Catalyst Clinical Research
Catalyst Clinical Research, a clinical research
organization (CRO), provides highly customizable solutions to the
global biopharmaceutical and biotechnology industries through two
established solutions: Catalyst Oncology and
Catalyst Flex. Catalyst Oncology provides full-service
specialty oncology CRO offerings while Catalyst Flex delivers
multi-therapeutic customer- or Catalyst-managed functional (FSP)
services. With more than 1,000 staff and several offices in
the United States, Europe, and the Asia-Pacific region, Catalyst's flexible
service model is built from more than a decade of listening to
customers, devising customer-centric solutions, and helping
customers advance their clinical studies by leveraging expert
teams and innovative technologies. Visit Catalyst online at
CatalystCR.com. Follow @CatalystCR on LinkedIn.
Catalyst is a portfolio company of QHP Capital, a leading
healthcare and life sciences investment firm.
Media Contact:
Elizabeth Humphrey
Elizabeth.Humphrey@CatalystCR.com
+1 (984) 459-2090
View original content to download
multimedia:https://www.prnewswire.com/news-releases/catalyst-clinical-research-again-named-one-of-the-fastest-growing-private-companies-302225304.html
SOURCE Catalyst Clinical Research